Sleep-disordered breathing in patients with heart failure

Heart Failure Clinics

Volumn 10, Issue 2, 2014, Pages 243-250

  Mentz, Robert J ^a   Fiuzat, Mona ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adaptive servoventilation; Clinical trials; Comorbidities; Heart failure; Outcomes; Positive airway pressure; Sleep apnea

Indexed keywords

COMORBIDITY; HEART FAILURE; HUMAN; HYPERCAPNIA; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; OXYGEN DESATURATION; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; REVIEW; SLEEP DISORDERED BREATHING; COMPLICATION; SLEEP APNEA SYNDROMES;

HEART FAILURE; HUMANS; SLEEP APNEA SYNDROMES;

EID: 84896399326     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2013.10.001     Document Type: Review

References (65)

1. Massie B.M., O'Connor C.M., Metra M., et al. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. NEngl J Med 2010, 363(15):1419-1428.
2. Gheorghiade M., Bohm M., Greene S.J., et al. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA 2013, 309(11):1125-1135.
3. Swedberg K., Young J.B., Anand I.S., et al. Treatment of anemia with darbepoetin alfa in systolic heart failure. NEngl J Med 2013, 368(13):1210-1219.
4. Felker G.M., Pang P.S., Adams K.F., et al. Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward. Circ Heart Fail 2010, 3(2):314-325.
5. Mentz R.J., Felker G.M. Noncardiac comorbidities and acute heart failure patients. Heart Fail Clin 2013, 9(3):359-367.
6. Braunstein J.B., Anderson G.F., Gerstenblith G., et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. JAm Coll Cardiol 2003, 42(7):1226-1233.
7. O'Connor C.M., Miller A.B., Blair J.E., et al. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) program. Am Heart J 2010, 159(5):841-849.e1.
8. Ferrier K., Campbell A., Yee B., et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005, 128(4):2116-2122.
9. Kasai T., Bradley T.D. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. JAm Coll Cardiol 2011, 57(2):119-127.
10. Young T., Shahar E., Nieto F.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the sleep heart health study. Arch Intern Med 2002, 162(8):893-900.
11. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22(5):667-689.
12. 2 and circulatory delay. Circulation 2001, 103(2):238-243.
13. Oldenburg O., Lamp B., Faber L., et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9(3):251-257.
14. Vazir A., Hastings P.C., Dayer M., et al. Ahigh prevalence of sleep disordered breathing in men with mild symptomatic chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007, 9(3):243-250.
15. Khayat R.N., Jarjoura D., Patt B., et al. In-hospital testing for sleep-disordered breathing in hospitalized patients with decompensated heart failure: report of prevalence and patient characteristics. JCard Fail 2009, 15(9):739-746.
16. Padeletti M., Green P., Mooney A.M., et al. Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med 2009, 10(3):353-360.
17. Paulino A., Damy T., Margarit L., et al. Prevalence of sleep-disordered breathing in a 316-patient French cohort of stable congestive heart failure. Arch Cardiovasc Dis 2009, 102(3):169-175.
18. Bitter T., Faber L., Hering D., et al. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail 2009, 11(6):602-608.
19. Chan J., Sanderson J., Chan W., et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997, 111(6):1488-1493.
20. Herrscher T.E., Akre H., Overland B., et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. JCard Fail 2011, 17(5):420-425.
21. Sin D.D., Fitzgerald F., Parker J.D., et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999, 160(4):1101-1106.
22. Bradley T.D., Floras J.S. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003, 107(12):1671-1678.
23. Marin J.M., Carrizo S.J., Vicente E., et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005, 365(9464):1046-1053.
24. Punjabi N.M., Caffo B.S., Goodwin J.L., et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009, 6(8):e1000132.
25. Gami A.S., Olson E.J., Shen W.K., et al. Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. JAm Coll Cardiol 2013, 62(7):610-616.
26. Khayat R., Abraham W., Patt B., et al. Central sleep apnea is a predictor of cardiac readmission in hospitalized patients with systolic heart failure. JCard Fail 2012, 18(7):534-540.
27. Wang H., Parker J.D., Newton G.E., et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. JAm Coll Cardiol 2007, 49(15):1625-1631.
28. Javaheri S., Shukla R., Zeigler H., et al. Central sleepapnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. JAm Coll Cardiol 2007, 49(20):2028-2034.
29. Lanfranchi P.A., Braghiroli A., Bosimini E., et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999, 99(11):1435-1440.
30. Yumino D., Wang H., Floras J.S., et al. Relationship between sleep apnoea and mortality in patients with ischaemic heart failure. Heart 2009, 95(10):819-824.
31. Roebuck T., Solin P., Kaye D.M., et al. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004, 23(5):735-740.
32. White D.P. Pathogenesis of obstructive and central sleep apnea. Am J Respir Crit Care Med 2005, 172(11):1363-1370.
33. Ng A.C., Freedman S.B. Sleep disordered breathing in chronic heart failure. Heart Fail Rev 2009, 14(2):89-99.
34. Arzt M., Young T., Finn L., et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006, 166(16):1716-1722.
35. Yumino D., Redolfi S., Ruttanaumpawan P., et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010, 121(14):1598-1605.
36. Ryan C.M., Floras J.S., Logan A.G., et al. Shift in sleep apnoea type in heart failure patients in the CANPAP trial. Eur Respir J 2010, 35(3):592-597.
37. Javaheri S. Amechanism of central sleep apnea in patients with heart failure. NEngl J Med 1999, 341(13):949-954.
38. Dempsey J.A. Crossing the apnoeic threshold: causes and consequences. Exp Physiol 2005, 90(1):13-24.
39. Solin P., Bergin P., Richardson M., et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99(12):1574-1579.
40. Punjabi N.M., Beamer B.A. Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 2009, 179(3):235-240.
41. Lavie P., Herer P., Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320(7233):479-482.
42. Gami A.S., Pressman G., Caples S.M., et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004, 110(4):364-367.
43. Peker Y., Carlson J., Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006, 28(3):596-602.
44. Erman M.K., Stewart D., Einhorn D., et al. Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device. JClin Sleep Med 2007, 3(4):387-392.
45. Usui K., Bradley T.D., Spaak J., et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. JAm Coll Cardiol 2005, 45(12):2008-2011.
46. Mansfield D.R., Gollogly N.C., Kaye D.M., et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004, 169(3):361-366.
47. Gilman M.P., Floras J.S., Usui K., et al. Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 2008, 114(3):243-249.
48. Kaneko Y., Floras J.S., Usui K., et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. NEngl J Med 2003, 348(13):1233-1241.
49. Yoshinaga K., Burwash I.G., Leech J.A., et al. The effects of continuous positive airway pressure on myocardial energetics in patients with heart failure and obstructive sleep apnea. JAm Coll Cardiol 2007, 49(4):450-458.
50. Smith L.A., Vennelle M., Gardner R.S., et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 2007, 28(10):1221-1227.
51. Doherty L.S., Kiely J.L., Swan V., et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005, 127(6):2076-2084.
52. Campos-Rodriguez F., Pena-Grinan N., Reyes-Nunez N., et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005, 128(2):624-633.
53. Campos-Rodriguez F., Martinez-Garcia M.A., de la Cruz-Moron I., et al. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment: a cohort study. Ann Intern Med 2012, 156(2):115-122.
54. Kasai T., Narui K., Dohi T., et al. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 2008, 133(3):690-696.
55. Olson L.J., Somers V.K. Treating central sleep apnea in heart failure: outcomes revisited. Circulation 2007, 115(25):3140-3142.
56. Stanchina M.L., Ellison K., Malhotra A., et al. The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study. Chest 2007, 132(2):433-439.
57. Oldenburg O., Faber L., Vogt J., et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 2007, 9(8):820-826.
58. Bradley T.D., Floras J.S. Sleep apnea and heart failure: part II: central sleep apnea. Circulation 2003, 107(13):1822-1826.
59. Sin D.D., Logan A.G., Fitzgerald F.S., et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000, 102(1):61-66.
60. Bradley T.D., Logan A.G., Kimoff R.J., et al. Continuous positive airway pressure for central sleep apnea and heart failure. NEngl J Med 2005, 353(19):2025-2033.
61. Arzt M., Floras J.S., Logan A.G., et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial (CANPAP). Circulation 2007, 115(25):3173-3180.
62. Sharma B.K., Bakker J.P., McSharry D.G., et al. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 2012, 142(5):1211-1221.
63. Pepperell J.C., Maskell N.A., Jones D.R., et al. Arandomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am J Respir Crit Care Med 2003, 168(9):1109-1114.
64. Kasai T., Kasagi S., Maeno K., et al. Adaptive servo-ventilation in cardiac function and neurohormonal status in patients with heart failure and central sleep apnea nonresponsive to continuous positive airway pressure. JACC: Heart Fail 2013, 1(1):58-63.
65. Gottlieb D.J., Craig S.E., Lorenzi-Filho G., et al. Sleep apnea cardiovascular clinical trials-current status and steps forward: the International Collaboration of Sleep Apnea Cardiovascular Trialists. Sleep 2013, 36(7):975-980.